In drug discovery, building complex molecules quickly is the name of the game.

A feature News and Perspectives story on technological advances in oncology was published in Journal of Medical Internet ...

Anthropic will start an internal drug discovery program, part of a new push to sell artificial intelligence tools to ...

Heart failure affects more than 64 million people worldwide and remains a leading driver of cardiovascular morbidity and mortality. Adverse cardiac ...

Artificial intelligence has already made its mark in commercial industries, and there's a good argument to be made that AI is ...

The partnership will connect Evogene’s AI-based ChemPass AI with the BCDD’s laboratory infrastructure.

Quick ReadAI cuts drug discovery from years to weeks, targeting a 10-15 year pipeline where 90% of candidates never reach ...

This article explores how new approach methodologies are transforming drug discovery through human-relevant models, including ...

At the moment, many of the big AI systems used in drug discovery are closed-source, meaning they are proprietary and carry an ...

Takeda will pay Insilico to use its proprietary Pharma.AI platform to advance drug candidates across several therapeutic ...

The deal could include further milestone payments, potentially bringing the total value to approximately $600m.

ast June, when AI drug discovery startup Chai Discovery was just 15 months old, it released a new model that could design antibodies. Nearly 20 pharma companies reached out to talk. “It was like we ...